Home » Stocks » Repare Therapeutics

Repare Therapeutics, Inc. (RPTX)

Stock Price: $25.15 USD -1.11 (-4.23%)
Updated Jul 10, 2020 4:00 PM EDT - Market closed
After-hours: $25.16 +0.01 (0.04%) Jul 10, 4:24 PM

Stock Price Chart

Key Info

Market Cap 922.20M
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 35.02M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 10, 2020
Last Price $25.15
Previous Close $26.26
Change ($) -1.11
Change (%) -4.23%
Day's Open 25.84
Day's Range 25.05 - 26.10
Day's Volume 169,244
52-Week Range 25.01 - 34.00

More Stats

Market Cap 922.20M
Enterprise Value 839.18M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 35.02M
Float 761,002
EPS (basic) n/a
EPS (diluted) n/a
FCF / Share n/a
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 60,667
Short Ratio n/a
Short % of Float n/a
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio n/a
Revenue n/a
Operating Income n/a
Net Income n/a
Free Cash Flow n/a
Net Cash 83.02M
Net Cash / Share 2.26
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA n/a
ROE n/a
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

*No analysts have provided price targets for this stock.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Operating Income-26.38-12.82-6.18
Net Income-27.22-14.28-7.80
Shares Outstanding1.531.531.52
Earnings Per Share-17.81-9.35-5.12
Operating Cash Flow-18.43-12.62-6.01
Capital Expenditures-1.30-0.58-1.16
Free Cash Flow-19.73-13.20-7.16
Cash & Equivalents95.0110.930.00
Total Debt1.06--
Net Cash / Debt93.9410.930.00
Book Value-46.13-22.38-
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Repare Therapeutics, Inc.
Country Canada
Employees 64
CEO Lloyd M. Segal

Stock Information

Ticker Symbol RPTX
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: RPTX
IPO Date June 19, 2020


Repare Therapeutics Inc., a precision oncology company, discovers and develops novel therapeutics by using its synthetic lethality approach in Canada. The company use its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. Its lead product candidate is RP-3500, an oral small molecule inhibitor for the treatment of solid tumors with specific DNA damage repair-related genomic alterations. It also develops CCNE1-SL inhibitor, a proprietary drug discovery program for tumors with amplification of CCNE1; and Polymerase Theta program, a SL target associated with BRCA mutations and other genomic alterations. The company was founded in 2016 and is headquartered in Montréal, Canada.